Glonghui December 15: Some investors asked Renhe Pharmaceutical (000650.SZ) on the investor interactive platform, “Has your company expanded the R&D and production volume of children's medicines?” The company replied that the company produces or sells many categories of children's drugs, and that products under development include oseltamivir phosphate dry suspensions, etc.
仁和药业(000650.SZ)：有较多品类品规的儿童药品生产或销售
Renhe Pharmaceutical (000650.SZ): Production or sale of children's drugs with a wide range of product regulations
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.